The Quick Five about Zika: Fast and Furious

Activity Preview

Zika infection is associated with fetal microcephaly, infant brain damage, and multiple neurological conditions in adults. There have been several cases of sexual transmission from travelers returning from Zika endemic areas. Not all pharmacists know the signs and symptoms of Zika infection. So much is unknown about this virus and not all pharmacists know how to counsel their patients about preventative and management strategies when it comes to Zika infection.

Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

1. Summarize results and implications of recent Zika studies

Activity Type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of CPE credit (0.05 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-16-134-H04-P.

To credit for completing “The Quick Five about Zika: Fast and Furious,” participants must complete the case challenge, evaluation questions, and then claim credit. Participants will need to have a valid pharmacist.com username and password to claim credit. After your credit has been claimed, please visit CPE monitor for your transcript.  

Initial Release Date: August 31, 2016 

Expiration Date: August 31, 2019 - NO CREDIT GRANTED AFTER THIS DATE

Development

"The Quick Five about Zika: Fast and Furious" is a chome-study continuing education activity for pharmacists and pharmacy technicians developed by the American Pharmacists Association.

Advisory Board

Disclosures

Meghan N. Jeffres, PharmD declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria.

APhA’s education staff declares no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete APhA staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures  

Activity Fee

There is no fee associated with this activity.

System Requirements

Computer and Internet access is required to complete this activity.  Please visit our website to view the System Requirements to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-16-134-H04-P 0.05 CEUs August 31, 2016 - August 31, 2019